Kevin S. Chu
- Biomaterials top 5%
- Biomedical Engineering top 10%
- Molecular Biology
- Atmospheric Science top 10%
- Health, Toxicology and Mutagenesis top 5%
- Co-authors
- Joseph M. DeSimoneJ. Christopher LuftMary E. NapierWilliam C. ZamboniCharles J. BowermanWarefta HasanOrlando CoronellRyan Kingsbury
- Topics
- Nanoparticle-Based Drug Delivery (8 papers)Atmospheric chemistry and aerosols (3 papers)Cancer Treatment and Pharmacology (3 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Kevin S. Chu
15 papers receiving 953 citations
Peers
Comparison fields: 5 of 102
- Biomaterials 350
- Biomedical Engineering 333
- Molecular Biology 267
- Atmospheric Science 256
- Health, Toxicology and Mutagenesis 182
Countries citing papers authored by Kevin S. Chu
This map shows the geographic impact of Kevin S. Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin S. Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin S. Chu more than expected).
Fields of papers citing papers by Kevin S. Chu
This network shows the impact of papers produced by Kevin S. Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin S. Chu. The network helps show where Kevin S. Chu may publish in the future.
Co-authorship network of co-authors of Kevin S. Chu
This figure shows the co-authorship network connecting the top 25 collaborators of Kevin S. Chu. A scholar is included among the top collaborators of Kevin S. Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin S. Chu. Kevin S. Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 37 | |
| 2 | 92 | |
| 3 | 96 | |
| 4 | 25 | |
| 5 | 74 | |
| 6 | 26 | |
| 7 | 34 | |
| 8 | 37 | |
| 9 | 125 | |
| 10 | 10 | |
| 11 | 100 | |
| 12 | 3 | |
| 13 | 127 | |
| 14 | 143 | |
| 15 | 48 |
About Kevin S. Chu
Kevin S. Chu is a scholar working on Biomaterials, Pharmaceutical Science and Oncology, having authored 15 papers that have together received 977 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (8 papers), Atmospheric chemistry and aerosols (3 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Biomaterials (350 citations), Atmospheric Science (256 citations) and Health, Toxicology and Mutagenesis (182 citations). Kevin S. Chu has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Joseph M. DeSimone, J. Christopher Luft, Mary E. Napier, William C. Zamboni, Charles J. Bowerman, Warefta Hasan, Orlando Coronell, Ryan Kingsbury, Ying‐Hsuan Lin and Jason D. Surratt. Their work appears in journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Nano Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.